Limited evidence on efficacy of hydroxychloroquine to deal with COVID-19, not enough proof to advise it for public: ICMR official.

PTI | New Delhi | Updated: 06-04-2020 16:29 IST | Created: 06-04-2020 16:29 IST

Limited evidence on efficacy of hydroxychloroquine to deal with COVID-19, not enough proof to advise it for public: ICMR official.

Country:
India

Limited evidence on efficacy of hydroxychloroquine to deal with COVID-19, not enough proof to advise it for public: ICMR official.

TRENDING

1

L'Oreal explores unloading chemical-related liabilities, WSJ reports

L'Oreal explores unloading chemical-related liabilities, WSJ reports

Global

2

Trump heads to Nebraska as Republicans defend Senate seat

Trump heads to Nebraska as Republicans defend Senate seat

Global

3

Trump signs order to expand access to tax-exempt diesel

Trump signs order to expand access to tax-exempt diesel

Global

4

Australia's ABC rejects AI copyright carveout, believes already been scraped

Australia's ABC rejects AI copyright carveout, believes already been scraped

Global

PERSPECTIVES AND INSIGHTS

Somalia’s Remittance Lifeline Breaks Down When Crisis Hits Everyone

AI Won’t Save the SDGs Alone, But It Could Build the Workforce That Can

From Imports to Industry: How Vietnam Built a Solar Export Powerhouse on Chinese Supply Chains

Can Social Protection Create Better Jobs? World Bank’s 500 Million Target Faces a Major Test

DevShots

Latest News

Connect us on

Facebook Twitter LinkedIn Quora Youtube

Google News RSS

Give Feedback

Use this form for editorial or site feedback. We usually reply within 2 to 3 working days.

Name

Email

Message

By submitting, you agree that we may use your email address to respond.

Web Analytics Made Easy - Statcounter